Levofloxacin 500 mg (Tab)
Brand Name: LEVYOSELLE
Levofloxacin 500 mg
Product Overview
- LEVYOSELLE is a broad-spectrum fluoroquinolone formulation containing Levofloxacin 500 mg. As the active S-enantiomer of ofloxacin, it penetrates cell membranes to selectively inhibit bacterial type II topoisomerases (DNA gyrase and topoisomerase IV). This action prevents DNA supercoiling, repair, and replication, producing rapid, concentration-dependent bactericidal activity against Gram-positive and Gram-negative pathogens.
- Designed for fast and effective infection control, this powerful antibiotic targets severe bacterial infections in the chest, sinuses, skin, or urinary tract by dismantling the DNA mechanisms bacteria need to multiply.
- Developed under stringent quality standards, LEVYOSELLE ensures consistent efficacy, safety, and patient compliance — empowering physicians to achieve optimal therapeutic outcomes in Complicated Respiratory, Sinus, and Urinary Tract Infections.
Therapeutic Benefits / Key Features
- Broad-spectrum fluoroquinolone activity with high bactericidal efficacy.
- Excellent oral bioavailability and tissue penetration.
- Effective against multidrug-resistant respiratory and urinary pathogens.
- Once-daily dosing for optimal compliance and convenience.
Brand Composition
Each film-coated tablet contains:
- Levofloxacin Hemihydrate I.P. equivalent to Levofloxacin 500 m
Why this formulation matters
- Ensures rapid bacterial clearance with sustained plasma levels.
- Suitable for moderate to severe infections across multiple systems.
- Proven clinical success in both inpatient and outpatient settings.
- Helps minimize recurrence through comprehensive infection control.
Division Identity
Part of YaselleZyntrix – Anti-Infectives & Critical Care Division
Precision antibiotics for a safer, infection-free tomorrow